期刊文献+

沐舒坦联合纳洛酮治疗胎粪吸入综合征74例临床观察

Evaluation for Effect of Mucosolvan in Combination with Naloxone on Meconium Aspiration Syndrome
下载PDF
导出
摘要 目的观察沐舒坦、纳洛酮联合治疗胎粪吸入综合征的疗效。方法自2003年1月~2007年1月在我科就诊的胎粪吸入综合征74例,随机分为治疗组40例和对照组34例。两组均给予常规治疗,治疗组在常规治疗基础上加用沐舒坦、纳洛酮,其中沐舒坦每次7.5mg/kg,q6h1次;纳洛酮针首次负荷量0.1mg/kg静推,1h后按0.01mg(/kg·h)的速度经微量输液泵持续静脉注射,每日总量不超过0.4mg/kg。结果在治疗结束时,治疗组显效27例(67.5%),有效11例(27.5%),总有效率为95.0%(38/40);对照组显效15例(44.1%),有效10例(29.4%),总有效率为73.5%(25/34)。两组显效率比较差异有显著性意义(χ2=4.09,P<0.05),总有效率比较差异有非常显著性意义(χ2=6.69,P<0.01)。结论沐舒坦联合纳洛酮治疗胎粪吸入综合征疗效显著,值得临床进一步研究。 Objective To evaluate the effect of mucosolvan in combination with naloxone on meconium aspiration syndrome(MAS). Methods Seventy-four patients with MAS in our department from January 2003 to January 2007, were divided randomly into control grnup(n=34) and treatment group(n=40). All patients were treated by conventional therapy,and treatment group were given combined with mucosolvan and naloxone, and mucosolvan(7.5mg/kg) was given every six hour; naloxone(0.1mg/kg) was injected into the bloodstream for the first time,after an hour was given at the stable rate of 0.01mg/kg an hour by microtransfuseon system[total≤0.4mg/(kg· d)]. Results At the end of the course,27 newborns in the treatment group had remarkable effect with the rate of 67.5%(27/40), ll cases had effect with the rate of 27.5%(11/40), the total rate was 95.0%(38/40). And 15 cases in the control group had remarkable effect with the rate of 44.1%(15/34), 10 cases had effect with the rate of 29.4%(10/34), the total rate was 73.5%(25/34). There was significant difference between the two groups in the remarkable rate,and very significant difference between the two groups in the remarkable. Conclusion There are a significant curative effect of the patients with MAS after given mucosolvan and naloxone,and worth further investigating.
出处 《中国现代医生》 2008年第26期33-34,共2页 China Modern Doctor
关键词 沐舒坦 纳洛酮 胎粪吸入 Mucosolvam Naloxone MAS
  • 相关文献

参考文献4

二级参考文献29

  • 1卢晓欣,林葆城,王成海,洪新如,陈新民,王永午.β-内啡肽在新生鼠缺氧缺血性脑损伤中的作用[J].中国应用生理学杂志,1994,10(1):45-48. 被引量:91
  • 2Lotze A, Mitchell BR, Bulas DI, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr, 1998,132: 40-47.
  • 3Soll RF, Dargaville PA. Surfactant for meconium aspiration syndrome in full term infants (Cochrane Review). http://www.update-software. com/Abstracts/ab002054.htm.2005-04-19.
  • 4Sun B, Curstedt T, Lindgren G, et al. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur Respir J, 1997,10: 1967-1974.
  • 5Herting E, Rauprich P, Stichtenoth G, et al. Resistance of difference surfactant preparations to inactivation by meconium. Pediatr Res, 2001,50: 44-49.
  • 6Tokieda K, Ikegami M, Wert SE, et al. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr Res, 1999,46: 708-714.
  • 7Vazquez de Anda GF, Lachmann RA, Gommers D, et al. Treatment of ventilation-induced lung injury with exogenous surfactant. Intensive Care Med, 2001,27: 559-565.
  • 8Walti H, Polla BS, Bachelet M. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr Res, 1997,41: 114-119.
  • 9Cao L, Qian LL, Zhu YR, et al. Regulation of activity of nuclear factor-kB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol Sin, 2003, 24: 1316-1323.
  • 10Hilgendorff A, Rawer D, Doerner M, et al. Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration. Intensive Care Med, 2003,29: 2247-2254.

共引文献372

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部